Access cutting-edge age-related macular degeneration treatment through this clinical trial at a research site in Fresno. Study-provided care at no cost to qualified participants.
Access age-related macular degeneration specialists in Fresno at no cost
This study follows strict safety protocols and ethical guidelines
All study-related age-related macular degeneration treatment provided free
This study is researching experimental (study) drugs called pozelimab and cemdisiran. The study is focused on participants who have Geographic Atrophy (GA) caused by Age-related Macular Degeneration (AMD). Geographic atrophy is a medical term that refers to later-stage cases of AMD which is an eye condition affecting central vision (what one sees straight ahead). The purpose of this study is to evaluate the progression rate of Geographic Atrophy in eyes of patients treated with cemdisiran alone
Sponsor: Regeneron Pharmaceuticals
Check if you qualify for this age-related macular degeneration clinical trial in Fresno, CA
If you're searching for age-related macular degeneration treatment options in Fresno, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fresno research site is actively enrolling participants for this clinical trial. You'll receive care from experienced age-related macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.